Summary of Classification and Labelling
Notified classification and labelling
General Information
947-528-6 |
1,1,3,3-Tetraoctyl-1-3-bis((2,2,3,5-oxotetramethylhexyl)oxy)distannoxane, dimer |
|
Notified classification and labelling according to CLP criteria
STOT SE 2 |
H371
(immune system)
(oral)
|
H371
(immune system)
|
|
GHS08 Wng
|
|
|
|
|
1 |
|
View details
|
Number of Aggregated Notifications: 1